Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasidotin (ILX651) in Advanced NSCLC
NCT00078455Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tasidotin in non-small cell lung carcinoma (NSCLC), sponsored by Sanofi. Started Dec 2003; status: completed.
02
Drugs
tasidotin
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT00078455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078455.